Covid-19 update: South Africa reports 7,523 new cases

National Institute of Infectious DiseasesNICD), a division of the National Health Laboratory Service, has reported 7,523 new cases of Covid-19 in South Africa in the past 24 hours.

This brings the total number of laboratory-confirmed cases to 3,852,148. This increase represents a positive outcome rate of 23.0%.

Today, the majority of new cases are in Gauteng (38%), followed by KwaZulu-Natal (24%). The Western Cape accounted for 17%; The Eastern Cape was 8%; The Free State accounted for 5%; the Northwest accounted for 4%; Mpumalanga accounted for 3%; and Limpopo and the Northern Cape each accounted for 1% of today’s new cases, respectively.

The country also recorded 26 deaths, of which 8 occurred in the last 24-48 hours. To date, the total number of deaths from Covid-19 is 100,559.

24,726,029 tests were carried out in both the public and private sectors.

Over the past 24 hours, the number of hospitalizations has increased by 148.

The South African Health Products Regulatory Authority (SAHPRA) has not yet clarified the details related to the side effects associated with the Johnson and Johnson Covid-19 vaccine.

Researchers from Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention found that the vaccine resulted in 60 confirmed cases of thrombosis with thrombocytopenia syndrome.

This leads to rare but potentially life-threatening blood clots one to two weeks after vaccination, according to the FDA.

With several vaccines available, the FDA has decided to keep the J&J vaccine for use only when no other options are available.

Peter Marks, director of the FDA’s Center for Biological Evaluation and Research, said the institution recognizes that the Janssen Covid-19 vaccine still plays a role in the current pandemic response in the United States and around the world.

READ MORE: Sahpra reviews side effects associated with Johnson & Johnson’s Covid-19 vaccine.

Additional reporting on Faizel Patel